RELATIONSHIP OF FETAL MACROSOMIA TO MATERNAL POSTPRANDIAL GLUCOSE CONTROL DURING PREGNANCY

被引:228
作者
COMBS, CA
GUNDERSON, E
KITZMILLER, JL
GAVIN, LA
MAIN, EK
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT OBSTET,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,DEPT GYNECOL & REPROD SCI,SAN FRANCISCO,CA 94143
[4] CHILDRENS HOSP,SAN FRANCISCO,CA 94119
关键词
D O I
10.2337/diacare.15.10.1251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To determine the gestational ages at which maternal hyperglycemia is most closely related to fetal macrosomia; to determine whether macrosomia is related to elevations of fasting glucose, postprandial glucose, or both; and to assess the relationship of macrosomia to maternal insulin dose and caloric intake. RESEARCH DESIGN AND METHODS - One hundred eleven consecutive pregnant women with Class B through RF diabetes were studied longitudinally from 13 to 36 wk gestation. Macrosomia was defined by birthweight >90th percentile for gestational age based on California norms. Women who delivered macrosomic infants were compared with those without macrosomic infants on pre- and postprandial blood glucose, GHb, insulin dose, macronutrient intake, and several other maternal variables. RESULTS - Macrosomia occurred in 32 (29%) cases, although several measures indicated reasonable glycemic control throughout pregnancy. Women delivering macrosomic infants did not differ from those without macrosomic infants in maternal age, prepregnant weight, duration of diabetes, White class, macronutrient intake, GHb, or fasting glucose. Macrosomia was associated with higher postprandial glucose levels up to 32 wk gestation and lower insulin doses from 29 to 36 wk gestation. In multiple logistic regression, macrosomia was significantly associated with postprandial glucose only between 29 and 32 wk gestation. Postprandial glucose values < 7.3 mM (<130 mg/dl) were associated with a higher risk of small-for-gestational-age infants (18%) compared with values above this level (1%). CONCLUSIONS - Because macrosomia was related to postprandial glucose but not fasting glucose, we conclude that postprandial glucose measurement should be a part of routine care for diabetes in pregnancy A target 1-h postprandial glucose value of 7.3 mM (130 mg/dl) may be the level that optimally reduces the incidence of macrosomia without increasing the incidence of small-for-gestational-age infants.
引用
收藏
页码:1251 / 1257
页数:7
相关论文
共 31 条
  • [1] SIGNIFICANCE OF ABNORMAL GLUCOSE-TOLERANCE (HYPERGLYCEMIA AND HYPOGLYCEMIA) IN PREGNANCY
    ABELL, DA
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1979, 86 (03): : 214 - 221
  • [2] THE EFFECT OF PLASMA-GLUCOSE VARIABILITY ON NEONATAL OUTCOME IN THE PREGNANT DIABETIC PATIENT
    ARTAL, R
    GOLDE, SH
    DOREY, F
    MCCLELLAN, SN
    GRATACOS, J
    LIRETTE, T
    MONTORO, M
    WU, PYK
    ANDERSON, B
    MESTMAN, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 147 (05) : 537 - 541
  • [3] BERK MA, 1989, PEDIATRICS, V83, P1029
  • [4] RELATIONSHIP OF MATERNAL GLYCOSYLATED HEMOGLOBIN AND FETAL BETA-CELL ACTIVITY WITH BIRTH-WEIGHT
    CANO, A
    BARCELO, F
    FUENTE, T
    MARTINEZ, P
    PARRILLA, JJ
    ABAD, L
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1986, 22 (02) : 91 - 96
  • [5] COMBS CA, 1991, BAILLIERE CLIN OB GY, V5, P315
  • [6] DANDONA P, 1984, LANCET, V1, P737
  • [7] GREEN JR, 1989, OBSTET GYNECOL, V73, P732
  • [8] HANS M, 1991, EUR J OBSTET GYN R B, V39, P175
  • [9] MATERNAL POSTPRANDIAL GLUCOSE-LEVELS AND INFANT BIRTH-WEIGHT - THE DIABETES IN EARLY-PREGNANCY STUDY
    JOVANOVICPETERSON, L
    PETERSON, CM
    REED, GF
    METZGER, BE
    MILLS, JL
    KNOPP, RH
    AARONS, JH
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (01) : 103 - 111
  • [10] RELATIONSHIP BETWEEN NEONATAL BIRTH-WEIGHT AND MATERNAL PLASMA AMINO-ACID PROFILES IN LEAN AND OBESE NONDIABETIC WOMEN AND IN TYPE-I DIABETIC PREGNANT-WOMEN
    KALKHOFF, RK
    KANDARAKI, E
    MORROW, PG
    MITCHELL, TH
    KELBER, S
    BORKOWF, HI
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (03): : 234 - 239